smiles code,active ingredient,salt,relation,assay value,target disease,protein target,treatment concentration,treatment unit,exposure time (h),measurement,type,model type,description,dataset,REFERENCE_ID,ASSAY_TYPE,ASSAY_ORGANISM,ASSAY_STRAIN,TARGET_TYPE,SRC_ID,ASSAY_SOURCE,UPPER_VALUE,SD_MINUS,SD_PLUS,ACTIVITY_COMMENT
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 5 mg/kg, 20 adm days",set10-2,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 5 mg/kg, 20 adm days",set10-2,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 10 mg/kg, 20 adm days",set10-2,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 10 mg/kg, 20 adm days",set10-2,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,126.9,Isotonic phos buffer - pH 2,,,ug/ml,,Equilibrium,In Vitro,,"Solubility, 24 hour",set10-2,1.0,A,Isotonic phos buffer - pH 2,unknown,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,0.53,Human,,,none,,EH,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,0.55,Rat,,,none,,EH,In Vitro,,Metabolism,set10-2,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,4.5,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,1.6,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-2,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,85.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,59.0,Mouse,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-2,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,20.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,0.72,Mouse,,,none,,EH,In Vitro,,Metabolism,set10-2,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,30.0,Mouse,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-2,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,4.1,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,38.0,Rat,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-2,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,46.0,Rat,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-2,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,20.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-2,1.0,A,CYP3A4,unknown,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,0.38,Dog,,,none,,EH,In Vitro,,Metabolism,set10-2,1.0,A,Dog,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,0.01,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,13.0,Dog,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-2,1.0,A,Dog,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,130.0,Dog,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-2,1.0,A,Dog,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,37.71,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-2,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,0.01,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,5.47,s.f. LogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,s.f. LogD,pH 5,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,2.71,s.f. LogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,s.f. LogD,pH 2,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,92.4,10% serum RPMI,,,%,,% bound,In Vitro,,protein binding,set10-2,1.0,A,10% serum RPMI,media,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,1497.0,SGF - pH 1,,,ug/ml,,Equilibrium,In Vitro,,"Solubility, 24 hour",set10-2,1.0,A,SGF - pH 1,37oC,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,1.2,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-2,1.0,A,CYP3A4,terfenadine,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,7.4,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-2,1.0,A,CYP3A4,Nifedipine,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,97.7,Human,,,%,,% bound,In Vitro,,protein binding,set10-2,1.0,A,Human,Liver Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,98.8,dog,,,%,,% bound,In Vitro,,protein binding,set10-2,1.0,A,dog,plasma,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,75.9,FeSSIF,,,ug/ml,,Equilibrium,In Vitro,,"Solubility, 24 hour",set10-2,1.0,A,FeSSIF,37oC,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,1.3,FaSSIF,,,ug/ml,,Equilibrium,In Vitro,,"Solubility, 24 hour",set10-2,1.0,A,FaSSIF,37oC,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,97.3,rat,,,%,,% bound,In Vitro,,protein binding,set10-2,1.0,A,rat,plasma,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,98.6,mouse,,,%,,% bound,In Vitro,,protein binding,set10-2,1.0,A,mouse,plasma,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,2.62,PKA,,,none,,pKa(1),In Vitro,,pKa measurement,set10-2,1.0,A,PKA,unknown,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,97.5,human,,,%,,% bound,In Vitro,,protein binding,set10-2,1.0,A,human,plasma,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,0.0475,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,42.42,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-2,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,0.00699999999999999,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 adm days",set10-2,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 adm days",set10-2,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,5.54,s.f. LogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,s.f. LogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,5.44,s.f. LogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,s.f. LogD,water,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 adm days",set10-2,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,64.59,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-2,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,0.012,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,7.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-2,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,3.8,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,42.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,41.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,3.1,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-2,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,25.0,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-2,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,4.2,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,0.7,Human,,,none,,EH,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 adm days",set10-2,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,0.61,Human,,,none,,EH,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,4.2,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,25.0,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-2,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,3.1,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-2,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,63.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,28.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,3.8,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,56.98,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-2,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,6.6,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-2,1.0,A,CYP3A4,unknown,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,0.4005,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,59.32,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-2,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,0.008,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,0.63,Human,,,none,,EH,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,4.2,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,3.1,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-2,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,57.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,30.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,3.7,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,.,= ,0.002,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,.,= ,4.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-2,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,.,= ,84.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,.,= ,21.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,.,= ,0.82,Human,,,none,,EH,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,.,= ,61.47,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-2,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,.,= ,0.09,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,.,= ,19.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-2,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,.,= ,53.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,.,= ,33.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,.,= ,0.75,Human,,,none,,EH,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,.,= ,0.214,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,.,= ,0.008,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,.,= ,7.1,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-2,1.0,A,CYP3A4,unknown,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,.,= ,2.3,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,.,= ,38.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,.,= ,46.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,.,= ,6.3,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-2,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,.,= ,25.0,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-2,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,.,= ,2.9,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,.,= ,0.68,Human,,,none,,EH,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 adm days",set10-2,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 adm days",set10-2,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,3.7,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,50.0,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-2,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,6.3,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-2,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,41.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,42.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,3.2,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,66.78,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-2,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,1.03,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,61.05,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-2,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,0.0126,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,20.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-2,1.0,A,CYP3A4,unknown,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,0.67,Human,,,none,,EH,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,3.7,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,6.3,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-2,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,49.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,36.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,3.1,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,0.77,Human,,,none,,EH,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,3.7,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,6.3,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-2,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,28.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,61.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,3.2,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,0.0075,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,60.88,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-2,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 adm days",set10-2,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 adm days",set10-2,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,0.7,Human,,,none,,EH,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=S(=O)(Cc1ccccc1)Nc1cnccc1N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=S(=O)(Cc1ccccc1)Nc1cnccc1N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,0.018,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=S(=O)(Cc1ccccc1)Nc1cnccc1N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=S(=O)(Cc1ccccc1)Nc1cnccc1N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,0.029,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,.,= ,1.8,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,.,= ,15.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,.,= ,113.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,.,= ,3.1,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-2,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,.,= ,25.0,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-2,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,.,= ,2.4,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,.,= ,0.46,Human,,,none,,EH,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,.,= ,1.8,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,.,= ,10.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,.,= ,169.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,.,= ,6.3,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-2,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,.,= ,25.0,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-2,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,.,= ,2.4,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,.,= ,0.36,Human,,,none,,EH,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,.,= ,2.3,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,.,= ,0.0555,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,.,= ,25.0,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-2,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,.,= ,1.7,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,.,= ,0.018,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,.,= ,0.02906666666666666,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,.,= ,0.024,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,.,= ,144.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,.,= ,12.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,.,= ,2.5,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,.,= ,0.055,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,.,= ,0.4,Human,,,none,,EH,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,.,= ,3.0,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,.,= ,0.56,Human,,,none,,EH,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,.,= ,3.0,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,.,= ,25.0,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-2,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,.,= ,77.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,.,= ,22.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,.,= ,2.6,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,.,= ,25.0,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-2,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,.,= ,0.08149999999999999,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,.,= ,0.0205,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,.,= ,2.6,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,.,= ,21.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,.,= ,81.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,.,= ,12.5,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-2,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,.,= ,3.0,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)nc3)CC2)c2cccnc2)cc1,.,= ,0.54,Human,,,none,,EH,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,.,= ,0.66,Human,,,none,,EH,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,.,= ,3.8,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,.,= ,3.1,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-2,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,.,= ,50.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,.,= ,35.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,.,= ,3.5,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,.,= ,0.01,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,.,= ,73.77,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-2,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,.,= ,0.027,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,.,= ,41.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,.,= ,42.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,.,= ,0.012,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,.,= ,58.22,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-2,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,.,= ,0.07150000000000001,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,.,= ,0.68,Human,,,none,,EH,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,.,= ,45.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,.,= ,0.0675,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,.,= ,54.66,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-2,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,.,= ,38.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2cccnc2)cc1,.,= ,0.7,Human,,,none,,EH,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(C)(C)OC(=O)N1CCN(C(=O)C(c2ccc(C#N)cc2)c2cccnc2)CC1,CC(C)(C)OC(=O)N1CCN(C(=O)C(c2ccc(C#N)cc2)c2cccnc2)CC1,.,= ,0.066,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,.,= ,0.05649999999999999,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,.,= ,0.023,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,.,= ,3.1,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,.,= ,29.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,.,= ,60.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,.,= ,6.3,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-2,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,.,= ,3.5,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,.,= ,0.62,Human,,,none,,EH,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,.,= ,0.56,Human,,,none,,EH,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,.,= ,3.1,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,.,= ,0.012,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,.,= ,0.012,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,.,= ,68.97,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-2,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,.,= ,68.97,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-2,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,.,= ,0.0465,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,.,= ,0.0465,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 adm days",set10-2,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 adm days",set10-2,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,.,= ,0.54,Human,,,none,,EH,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,.,= ,3.5,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,.,= ,6.3,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-2,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,.,= ,83.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,.,= ,21.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,.,= ,3.1,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,.,= ,78.74,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-2,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,.,= ,23.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,.,= ,77.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,.,= ,6.3,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-2,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,.,= ,50.0,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-2,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,N#Cc1ccc(C(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c2cccnc2)cc1,.,= ,3.5,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cncnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cncnc3)CC2)cc1,.,= ,0.79,Human,,,none,,EH,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cncnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cncnc3)CC2)cc1,.,= ,0.69,Human,,,none,,EH,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cncnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cncnc3)CC2)cc1,.,= ,0.66,Human,,,none,,EH,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cncnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cncnc3)CC2)cc1,.,= ,25.0,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-2,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cncnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cncnc3)CC2)cc1,.,= ,6.3,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-2,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cncnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cncnc3)CC2)cc1,.,= ,50.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cncnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cncnc3)CC2)cc1,.,= ,34.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cncnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cncnc3)CC2)cc1,.,= ,2.6,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cncnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cncnc3)CC2)cc1,.,= ,0.07833333333333332,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cncnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cncnc3)CC2)cc1,.,= ,25.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cncnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cncnc3)CC2)cc1,.,= ,69.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cncnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cncnc3)CC2)cc1,.,= ,0.0635,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cncnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cncnc3)CC2)cc1,.,= ,43.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cncnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cncnc3)CC2)cc1,.,= ,2.6,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cncnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCN(C(=O)C(c3ccc(Cl)cc3)c3cncnc3)CC2)cc1,.,= ,40.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,0.76,Human,,,none,,EH,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,3.3,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,12.5,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-2,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,12.5,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-2,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,31.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,56.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,3.4,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)nc2)CC1,.,= ,0.2525,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,0.81,Human,,,none,,EH,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,3.9,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,50.0,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-2,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,6.3,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-2,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,23.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,76.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,3.9,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,18.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-2,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,0.161,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cn2)CC1,.,= ,52.51,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-2,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,51.28,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-2,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,0.118,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,20.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-2,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,4.2,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,59.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,30.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,3.1,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-2,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,3.1,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-2,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,4.2,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-2,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,O=C(C(c1ccc(Cl)cc1)c1cncnc1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,.,= ,0.77,Human,,,none,,EH,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(c1ccc(Cl)cc1)N1CCN(C(=O)C(c2ccc(Cl)cc2)c2cccnc2)CC1,O=C(c1ccc(Cl)cc1)N1CCN(C(=O)C(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,0.022,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(c1ccccc1)N1CCN(C(=O)C(c2ccc(Cl)cc2)c2cccnc2)CC1,O=C(c1ccccc1)N1CCN(C(=O)C(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,0.04949999999999999,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2nccs2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(c2nccs2)CC1,.,= ,0.051,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(Cc2cccc(C(F)(F)F)c2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(Cc2cccc(C(F)(F)F)c2)CC1,.,= ,51.56,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-2,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(Cc2cccc(C(F)(F)F)c2)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(Cc2cccc(C(F)(F)F)c2)CC1,.,= ,0.01485,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(Cc2ccccc2C(F)(F)F)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(Cc2ccccc2C(F)(F)F)CC1,.,= ,0.96,Human,,,none,,EH,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(Cc2ccccc2C(F)(F)F)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(Cc2ccccc2C(F)(F)F)CC1,.,= ,4.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(Cc2ccccc2C(F)(F)F)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(Cc2ccccc2C(F)(F)F)CC1,.,= ,15.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-2,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(Cc2ccccc2C(F)(F)F)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(Cc2ccccc2C(F)(F)F)CC1,.,= ,460.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-2,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(Cc2ccccc2C(F)(F)F)CC1,O=C(C(c1ccc(Cl)cc1)c1cccnc1)N1CCN(Cc2ccccc2C(F)(F)F)CC1,.,= ,54.19,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-2,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CC(C)CN1CCN(C(=O)C(c2ccc(Cl)cc2)c2cccnc2)CC1,CC(C)CN1CCN(C(=O)C(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,0.065,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-2,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
